UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Similarweb
SMWB
$799M
| $692K | ﹤0.01% |
88,310
+38,218
| +76% | +$286K |
2024 Q2
4 quarters
|
|
|
AVDL
2452
DELISTED
Avadel Pharmaceuticals
AVDL
| $690K | ﹤0.01% |
77,955
+12,222
| +19% | +$107K |
2024 Q3
3 quarters
|
|
2453
Willdan Group
WLDN
$1.14B
| $686K | ﹤0.01% |
+10,979
| New | +$524K |
2025 Q2
0 quarters
|
|
2454
OrthoPediatrics
KIDS
$565M
| $685K | ﹤0.01% |
31,873
+20,641
| +184% | +$446K |
2024 Q2
4 quarters
|
|
2455
Granite Ridge Resources
GRNT
$629M
| $680K | ﹤0.01% |
106,735
+46,600
| +77% | +$257K |
2023 Q4
6 quarters
|
|
|
TTAN
2456
ServiceTitan Inc
TTAN
$7B
| $677K | ﹤0.01% |
+6,319
| New | +$706K |
2025 Q2
0 quarters
|
|
2457
Green Dot
GDOT
$719M
| $675K | ﹤0.01% |
62,625
-54,534
| -47% | -$493K |
2013 Q2
48 quarters
|
|
2458
SelectQuote
SLQT
$64.2M
| $659K | ﹤0.01% |
276,911
+108,187
| +64% | +$284K |
2025 Q1
1 quarter
|
|
2459
Krispy Kreme
DNUT
$514M
| $655K | ﹤0.01% |
225,007
+55,834
| +33% | +$195K |
2021 Q4
14 quarters
|
|
|
PDS
2460
Precision Drilling
PDS
$1.06B
| $648K | ﹤0.01% |
13,722
+2,308
| +20% | +$103K |
2024 Q2
4 quarters
|
|
2461
Vermilion Energy
VET
$1.81B
| $644K | ﹤0.01% |
88,473
-10,573
| -11% | -$72.1K |
2024 Q2
4 quarters
|
|
2462
ArriVent BioPharma
AVBP
$825M
| $643K | ﹤0.01% |
+29,555
| New | +$614K |
2025 Q2
0 quarters
|
|
2463
Chemours
CC
$2.05B
| $625K | ﹤0.01% |
54,605
-81,106
| -60% | -$914K |
2015 Q3
39 quarters
|
|
2464
Atlanticus Holdings
ATLC
$1.42B
| $610K | ﹤0.01% |
11,134
+5,134
| +86% | +$267K |
2025 Q1
1 quarter
|
|
2465
iShares US Medical Devices ETF
IHI
$3.55B
| $603K | ﹤0.01% |
+9,631
| New | +$579K |
2025 Q2
0 quarters
|
|
|
NUTX
2466
Nutex Health
NUTX
$1.41B
| $602K | ﹤0.01% |
+4,833
| New | +$624K |
2025 Q2
0 quarters
|
|
2467
Kimbell Royalty Partners
KRP
$1.54B
| $599K | ﹤0.01% |
42,944
-2,406
| -5% | -$31.5K |
2022 Q4
10 quarters
|
|
2468
HBT Financial
HBT
$1.27B
| $599K | ﹤0.01% |
23,759
+12,776
| +116% | +$299K |
2024 Q2
4 quarters
|
|
2469
Liquidia Corp
LQDA
$2.45B
| $597K | ﹤0.01% |
47,896
-73,860
| -61% | -$1.09M |
2024 Q1
5 quarters
|
|
|
DEFT
2470
Defi Technologies
DEFT
$181M
| $588K | ﹤0.01% |
+200,732
| New | +$672K |
2025 Q2
0 quarters
|
|
2471
TechTarget
TTGT
$285M
| $584K | ﹤0.01% |
75,171
+17,116
| +29% | +$136K |
2018 Q4
26 quarters
|
|
2472
KRONOS Worldwide
KRO
$876M
| $562K | ﹤0.01% |
90,702
+19,666
| +28% | +$135K |
2017 Q4
30 quarters
|
|
2473
Frontier Group Holdings
ULCC
$1.35B
| $559K | ﹤0.01% |
153,983
+61,595
| +67% | +$226K |
2021 Q2
16 quarters
|
|
|
GOGL
2474
DELISTED
Golden Ocean Group
GOGL
| $547K | ﹤0.01% |
74,746
-13,345
| -15% | -$101K |
2024 Q2
4 quarters
|
|
2475
iShares Select U.S. REIT ETF
ICF
$2.07B
| $542K | ﹤0.01% |
+8,862
| New | +$537K |
2025 Q2
0 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.